CME — CME GROUP INC

Ownership history in Phase 2 Partners, LLC  ·  5 quarters on record

This page tracks every 13F SEC filing in which Phase 2 Partners, LLC reported a position in CME GROUP INC (CME). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
8.6% (2023 Q1)
Avg. % of fund
3.1%
First filed
2021 Q4
Last filed
2024 Q3
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2024 Q3 ADDED 25,756 +23,991 +1359.3% 3.36% $5.7M $205.35
2023 Q2 REDUCED 1,765 -102,395 -98.3% 0.15% $327K $163.79
2023 Q1 ADDED 104,160 +100,140 +2491.0% 8.60% $19.9M $168.27
2022 Q1 REDUCED 4,020 -15,524 -79.4% 0.62% $956K $199.17
2021 Q4 INITIATED 19,544 — — 2.76% $4.5M $190.44
% of Fund (quarterly)    CME price (monthly, adj. close)

Other funds also holding CME

As of 2025 Q4 — sorted by position size

Vitol Holding B.V. 3Y 100.0% BP PLC 3Y 7Y 100.0% Kepos Capital LP 3Y 7Y 46.51% GUARDCAP ASSET MANAGEMENT Ltd 3Y 7Y 13.73% Prevatt Capital Ltd 12.8% CAPITAL COUNSEL LLC/NY 3Y 7Y 8.39% IRON Financial LLC 3Y 7Y 7.33% STEVENS CAPITAL MANAGEMENT LP 3Y 7Y 7.21% Patrick Mauro Investment Advisor, INC. 3Y 7.07% Emmett Investment Management, LP 6.89%
← Back to Phase 2 Partners, LLC Holdings